Emphysema Completed Phase 4 Trials for Alpha-1-proteinase inhibitor (DB00058)

Also known as: Bullous emphysema (lung)(pulmonary) / Pulmonary Emphysema / Emphysema pulmonary

IndicationStatusPhase
DBCOND0019688 (Emphysema)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00261833Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor DeficiencyTreatment
NCT00670007Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.Treatment